title: Discontinued drugs in 2007: cardiovascular drugs.
abstract: This perspective is part of an annual series of papers discussing drugs dropped from clinical development in the previous year. Specifically, this paper focuses on the 16 cardiovascular drugs discontinued in 2007. Information for this perspective was derived from a search of the Pharmaprojects database for drugs discontinued after reaching Phase I - III clinical trials.
authors.affiliation: China Pharmaceutical University, Center for Instrumental Analysis, Ministry of Education, Key Laboratory of Drug Quality Control & Pharmacovigilance, 210009, Nanjing, P.R. China. yxzxs@msn.com
authors.forename: Xu-Song
authors.initials: XS
authors.lastname: Zhang
authors.forename: Bing-Ren
authors.initials: BR
authors.lastname: Xiang
mesh_terms: D000818:Animals; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D013997:Time Factors
chemical_list: D002317:Cardiovascular Agents